0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecule Protein Degradation Agent Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-32G14680
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Small Molecule Protein Degradation Agent Market Research Report 2023
BUY CHAPTERS

Global Small Molecule Protein Degradation Agent Market Research Report 2025

Code: QYRE-Auto-32G14680
Report
May 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Small Molecule Protein Degradation Agent Market

The global market for Small Molecule Protein Degradation Agent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Small Molecule Protein Degradation Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Molecule Protein Degradation Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Small Molecule Protein Degradation Agent include BMS, Monte Rosa Therapeutics, Nurix, Novartis, Eisai, Boehringer Ingelheim, Proxygen, Merck Sharp & Dohme, Arvinas, Amgen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Small Molecule Protein Degradation Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Protein Degradation Agent.
The Small Molecule Protein Degradation Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Protein Degradation Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Protein Degradation Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Small Molecule Protein Degradation Agent Market Report

Report Metric Details
Report Name Small Molecule Protein Degradation Agent Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BMS, Monte Rosa Therapeutics, Nurix, Novartis, Eisai, Boehringer Ingelheim, Proxygen, Merck Sharp & Dohme, Arvinas, Amgen, Shanghai Meizhi Pharmaceutical, Fendi Technology, Five-Membered Creatures, Gluetacs Therapeutics, Hengrui Medicine, Degron Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Small Molecule Protein Degradation Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Small Molecule Protein Degradation Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Small Molecule Protein Degradation Agent Market report?

Ans: The main players in the Small Molecule Protein Degradation Agent Market are BMS, Monte Rosa Therapeutics, Nurix, Novartis, Eisai, Boehringer Ingelheim, Proxygen, Merck Sharp & Dohme, Arvinas, Amgen, Shanghai Meizhi Pharmaceutical, Fendi Technology, Five-Membered Creatures, Gluetacs Therapeutics, Hengrui Medicine, Degron Therapeutics

What are the Application segmentation covered in the Small Molecule Protein Degradation Agent Market report?

Ans: The Applications covered in the Small Molecule Protein Degradation Agent Market report are Oncology Treatment, Cancer Treatment, Treatment Of Neurodegenerative Diseases, Other

What are the Type segmentation covered in the Small Molecule Protein Degradation Agent Market report?

Ans: The Types covered in the Small Molecule Protein Degradation Agent Market report are Molecular Gel Degrader, Protein Degradation Targets Chimeras

Recommended Reports

Protein Degradation

Small Molecule Drugs

Neuro & Cancer Therapy

1 Small Molecule Protein Degradation Agent Market Overview
1.1 Product Definition
1.2 Small Molecule Protein Degradation Agent by Type
1.2.1 Global Small Molecule Protein Degradation Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Molecular Gel Degrader
1.2.3 Protein Degradation Targets Chimeras
1.3 Small Molecule Protein Degradation Agent by Application
1.3.1 Global Small Molecule Protein Degradation Agent Market Value by Application (2024 VS 2031)
1.3.2 Oncology Treatment
1.3.3 Cancer Treatment
1.3.4 Treatment Of Neurodegenerative Diseases
1.3.5 Other
1.4 Global Small Molecule Protein Degradation Agent Market Size Estimates and Forecasts
1.4.1 Global Small Molecule Protein Degradation Agent Revenue 2020-2031
1.4.2 Global Small Molecule Protein Degradation Agent Sales 2020-2031
1.4.3 Global Small Molecule Protein Degradation Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Small Molecule Protein Degradation Agent Market Competition by Manufacturers
2.1 Global Small Molecule Protein Degradation Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Small Molecule Protein Degradation Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Small Molecule Protein Degradation Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Small Molecule Protein Degradation Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Small Molecule Protein Degradation Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Small Molecule Protein Degradation Agent, Product Type & Application
2.7 Global Key Manufacturers of Small Molecule Protein Degradation Agent, Date of Enter into This Industry
2.8 Global Small Molecule Protein Degradation Agent Market Competitive Situation and Trends
2.8.1 Global Small Molecule Protein Degradation Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Small Molecule Protein Degradation Agent Players Market Share by Revenue
2.8.3 Global Small Molecule Protein Degradation Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Small Molecule Protein Degradation Agent Market Scenario by Region
3.1 Global Small Molecule Protein Degradation Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Small Molecule Protein Degradation Agent Sales by Region: 2020-2031
3.2.1 Global Small Molecule Protein Degradation Agent Sales by Region: 2020-2025
3.2.2 Global Small Molecule Protein Degradation Agent Sales by Region: 2026-2031
3.3 Global Small Molecule Protein Degradation Agent Revenue by Region: 2020-2031
3.3.1 Global Small Molecule Protein Degradation Agent Revenue by Region: 2020-2025
3.3.2 Global Small Molecule Protein Degradation Agent Revenue by Region: 2026-2031
3.4 North America Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.4.1 North America Small Molecule Protein Degradation Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Small Molecule Protein Degradation Agent Sales by Country (2020-2031)
3.4.3 North America Small Molecule Protein Degradation Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.5.1 Europe Small Molecule Protein Degradation Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Small Molecule Protein Degradation Agent Sales by Country (2020-2031)
3.5.3 Europe Small Molecule Protein Degradation Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Small Molecule Protein Degradation Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Small Molecule Protein Degradation Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Small Molecule Protein Degradation Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Small Molecule Protein Degradation Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.7.1 Latin America Small Molecule Protein Degradation Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Small Molecule Protein Degradation Agent Sales by Country (2020-2031)
3.7.3 Latin America Small Molecule Protein Degradation Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Small Molecule Protein Degradation Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Small Molecule Protein Degradation Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Small Molecule Protein Degradation Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Small Molecule Protein Degradation Agent Sales by Type (2020-2031)
4.1.1 Global Small Molecule Protein Degradation Agent Sales by Type (2020-2025)
4.1.2 Global Small Molecule Protein Degradation Agent Sales by Type (2026-2031)
4.1.3 Global Small Molecule Protein Degradation Agent Sales Market Share by Type (2020-2031)
4.2 Global Small Molecule Protein Degradation Agent Revenue by Type (2020-2031)
4.2.1 Global Small Molecule Protein Degradation Agent Revenue by Type (2020-2025)
4.2.2 Global Small Molecule Protein Degradation Agent Revenue by Type (2026-2031)
4.2.3 Global Small Molecule Protein Degradation Agent Revenue Market Share by Type (2020-2031)
4.3 Global Small Molecule Protein Degradation Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Small Molecule Protein Degradation Agent Sales by Application (2020-2031)
5.1.1 Global Small Molecule Protein Degradation Agent Sales by Application (2020-2025)
5.1.2 Global Small Molecule Protein Degradation Agent Sales by Application (2026-2031)
5.1.3 Global Small Molecule Protein Degradation Agent Sales Market Share by Application (2020-2031)
5.2 Global Small Molecule Protein Degradation Agent Revenue by Application (2020-2031)
5.2.1 Global Small Molecule Protein Degradation Agent Revenue by Application (2020-2025)
5.2.2 Global Small Molecule Protein Degradation Agent Revenue by Application (2026-2031)
5.2.3 Global Small Molecule Protein Degradation Agent Revenue Market Share by Application (2020-2031)
5.3 Global Small Molecule Protein Degradation Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BMS
6.1.1 BMS Company Information
6.1.2 BMS Description and Business Overview
6.1.3 BMS Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BMS Small Molecule Protein Degradation Agent Product Portfolio
6.1.5 BMS Recent Developments/Updates
6.2 Monte Rosa Therapeutics
6.2.1 Monte Rosa Therapeutics Company Information
6.2.2 Monte Rosa Therapeutics Description and Business Overview
6.2.3 Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Product Portfolio
6.2.5 Monte Rosa Therapeutics Recent Developments/Updates
6.3 Nurix
6.3.1 Nurix Company Information
6.3.2 Nurix Description and Business Overview
6.3.3 Nurix Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nurix Small Molecule Protein Degradation Agent Product Portfolio
6.3.5 Nurix Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Small Molecule Protein Degradation Agent Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Eisai
6.5.1 Eisai Company Information
6.5.2 Eisai Description and Business Overview
6.5.3 Eisai Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eisai Small Molecule Protein Degradation Agent Product Portfolio
6.5.5 Eisai Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Company Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Ingelheim Small Molecule Protein Degradation Agent Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Proxygen
6.7.1 Proxygen Company Information
6.7.2 Proxygen Description and Business Overview
6.7.3 Proxygen Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Proxygen Small Molecule Protein Degradation Agent Product Portfolio
6.7.5 Proxygen Recent Developments/Updates
6.8 Merck Sharp & Dohme
6.8.1 Merck Sharp & Dohme Company Information
6.8.2 Merck Sharp & Dohme Description and Business Overview
6.8.3 Merck Sharp & Dohme Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck Sharp & Dohme Small Molecule Protein Degradation Agent Product Portfolio
6.8.5 Merck Sharp & Dohme Recent Developments/Updates
6.9 Arvinas
6.9.1 Arvinas Company Information
6.9.2 Arvinas Description and Business Overview
6.9.3 Arvinas Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Arvinas Small Molecule Protein Degradation Agent Product Portfolio
6.9.5 Arvinas Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Company Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Amgen Small Molecule Protein Degradation Agent Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 Shanghai Meizhi Pharmaceutical
6.11.1 Shanghai Meizhi Pharmaceutical Company Information
6.11.2 Shanghai Meizhi Pharmaceutical Description and Business Overview
6.11.3 Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Product Portfolio
6.11.5 Shanghai Meizhi Pharmaceutical Recent Developments/Updates
6.12 Fendi Technology
6.12.1 Fendi Technology Company Information
6.12.2 Fendi Technology Description and Business Overview
6.12.3 Fendi Technology Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fendi Technology Small Molecule Protein Degradation Agent Product Portfolio
6.12.5 Fendi Technology Recent Developments/Updates
6.13 Five-Membered Creatures
6.13.1 Five-Membered Creatures Company Information
6.13.2 Five-Membered Creatures Description and Business Overview
6.13.3 Five-Membered Creatures Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Five-Membered Creatures Small Molecule Protein Degradation Agent Product Portfolio
6.13.5 Five-Membered Creatures Recent Developments/Updates
6.14 Gluetacs Therapeutics
6.14.1 Gluetacs Therapeutics Company Information
6.14.2 Gluetacs Therapeutics Description and Business Overview
6.14.3 Gluetacs Therapeutics Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Gluetacs Therapeutics Small Molecule Protein Degradation Agent Product Portfolio
6.14.5 Gluetacs Therapeutics Recent Developments/Updates
6.15 Hengrui Medicine
6.15.1 Hengrui Medicine Company Information
6.15.2 Hengrui Medicine Description and Business Overview
6.15.3 Hengrui Medicine Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hengrui Medicine Small Molecule Protein Degradation Agent Product Portfolio
6.15.5 Hengrui Medicine Recent Developments/Updates
6.16 Degron Therapeutics
6.16.1 Degron Therapeutics Company Information
6.16.2 Degron Therapeutics Description and Business Overview
6.16.3 Degron Therapeutics Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Degron Therapeutics Small Molecule Protein Degradation Agent Product Portfolio
6.16.5 Degron Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Small Molecule Protein Degradation Agent Industry Chain Analysis
7.2 Small Molecule Protein Degradation Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Small Molecule Protein Degradation Agent Production Mode & Process Analysis
7.4 Small Molecule Protein Degradation Agent Sales and Marketing
7.4.1 Small Molecule Protein Degradation Agent Sales Channels
7.4.2 Small Molecule Protein Degradation Agent Distributors
7.5 Small Molecule Protein Degradation Agent Customer Analysis
8 Small Molecule Protein Degradation Agent Market Dynamics
8.1 Small Molecule Protein Degradation Agent Industry Trends
8.2 Small Molecule Protein Degradation Agent Market Drivers
8.3 Small Molecule Protein Degradation Agent Market Challenges
8.4 Small Molecule Protein Degradation Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Small Molecule Protein Degradation Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Small Molecule Protein Degradation Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Small Molecule Protein Degradation Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Small Molecule Protein Degradation Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Small Molecule Protein Degradation Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Small Molecule Protein Degradation Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Small Molecule Protein Degradation Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Small Molecule Protein Degradation Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Small Molecule Protein Degradation Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Small Molecule Protein Degradation Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Small Molecule Protein Degradation Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Small Molecule Protein Degradation Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Protein Degradation Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Small Molecule Protein Degradation Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Small Molecule Protein Degradation Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Small Molecule Protein Degradation Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Small Molecule Protein Degradation Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Small Molecule Protein Degradation Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Small Molecule Protein Degradation Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Small Molecule Protein Degradation Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Small Molecule Protein Degradation Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Small Molecule Protein Degradation Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Small Molecule Protein Degradation Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Small Molecule Protein Degradation Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Small Molecule Protein Degradation Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Small Molecule Protein Degradation Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Small Molecule Protein Degradation Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Small Molecule Protein Degradation Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Small Molecule Protein Degradation Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Small Molecule Protein Degradation Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Small Molecule Protein Degradation Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Small Molecule Protein Degradation Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Small Molecule Protein Degradation Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Small Molecule Protein Degradation Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Small Molecule Protein Degradation Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Small Molecule Protein Degradation Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Small Molecule Protein Degradation Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Small Molecule Protein Degradation Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Small Molecule Protein Degradation Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Small Molecule Protein Degradation Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Small Molecule Protein Degradation Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Small Molecule Protein Degradation Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Small Molecule Protein Degradation Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Small Molecule Protein Degradation Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Small Molecule Protein Degradation Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Small Molecule Protein Degradation Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Small Molecule Protein Degradation Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Small Molecule Protein Degradation Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Small Molecule Protein Degradation Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Small Molecule Protein Degradation Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Small Molecule Protein Degradation Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Small Molecule Protein Degradation Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Small Molecule Protein Degradation Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Small Molecule Protein Degradation Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Small Molecule Protein Degradation Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Small Molecule Protein Degradation Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Small Molecule Protein Degradation Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Small Molecule Protein Degradation Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Small Molecule Protein Degradation Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. BMS Company Information
 Table 71. BMS Description and Business Overview
 Table 72. BMS Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. BMS Small Molecule Protein Degradation Agent Product
 Table 74. BMS Recent Developments/Updates
 Table 75. Monte Rosa Therapeutics Company Information
 Table 76. Monte Rosa Therapeutics Description and Business Overview
 Table 77. Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Product
 Table 79. Monte Rosa Therapeutics Recent Developments/Updates
 Table 80. Nurix Company Information
 Table 81. Nurix Description and Business Overview
 Table 82. Nurix Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Nurix Small Molecule Protein Degradation Agent Product
 Table 84. Nurix Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Small Molecule Protein Degradation Agent Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Eisai Company Information
 Table 91. Eisai Description and Business Overview
 Table 92. Eisai Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eisai Small Molecule Protein Degradation Agent Product
 Table 94. Eisai Recent Developments/Updates
 Table 95. Boehringer Ingelheim Company Information
 Table 96. Boehringer Ingelheim Description and Business Overview
 Table 97. Boehringer Ingelheim Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Boehringer Ingelheim Small Molecule Protein Degradation Agent Product
 Table 99. Boehringer Ingelheim Recent Developments/Updates
 Table 100. Proxygen Company Information
 Table 101. Proxygen Description and Business Overview
 Table 102. Proxygen Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Proxygen Small Molecule Protein Degradation Agent Product
 Table 104. Proxygen Recent Developments/Updates
 Table 105. Merck Sharp & Dohme Company Information
 Table 106. Merck Sharp & Dohme Description and Business Overview
 Table 107. Merck Sharp & Dohme Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Merck Sharp & Dohme Small Molecule Protein Degradation Agent Product
 Table 109. Merck Sharp & Dohme Recent Developments/Updates
 Table 110. Arvinas Company Information
 Table 111. Arvinas Description and Business Overview
 Table 112. Arvinas Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Arvinas Small Molecule Protein Degradation Agent Product
 Table 114. Arvinas Recent Developments/Updates
 Table 115. Amgen Company Information
 Table 116. Amgen Description and Business Overview
 Table 117. Amgen Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Amgen Small Molecule Protein Degradation Agent Product
 Table 119. Amgen Recent Developments/Updates
 Table 120. Shanghai Meizhi Pharmaceutical Company Information
 Table 121. Shanghai Meizhi Pharmaceutical Description and Business Overview
 Table 122. Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Product
 Table 124. Shanghai Meizhi Pharmaceutical Recent Developments/Updates
 Table 125. Fendi Technology Company Information
 Table 126. Fendi Technology Description and Business Overview
 Table 127. Fendi Technology Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Fendi Technology Small Molecule Protein Degradation Agent Product
 Table 129. Fendi Technology Recent Developments/Updates
 Table 130. Five-Membered Creatures Company Information
 Table 131. Five-Membered Creatures Description and Business Overview
 Table 132. Five-Membered Creatures Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Five-Membered Creatures Small Molecule Protein Degradation Agent Product
 Table 134. Five-Membered Creatures Recent Developments/Updates
 Table 135. Gluetacs Therapeutics Company Information
 Table 136. Gluetacs Therapeutics Description and Business Overview
 Table 137. Gluetacs Therapeutics Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Gluetacs Therapeutics Small Molecule Protein Degradation Agent Product
 Table 139. Gluetacs Therapeutics Recent Developments/Updates
 Table 140. Hengrui Medicine Company Information
 Table 141. Hengrui Medicine Description and Business Overview
 Table 142. Hengrui Medicine Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hengrui Medicine Small Molecule Protein Degradation Agent Product
 Table 144. Hengrui Medicine Recent Developments/Updates
 Table 145. Degron Therapeutics Company Information
 Table 146. Degron Therapeutics Description and Business Overview
 Table 147. Degron Therapeutics Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Degron Therapeutics Small Molecule Protein Degradation Agent Product
 Table 149. Degron Therapeutics Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Small Molecule Protein Degradation Agent Distributors List
 Table 153. Small Molecule Protein Degradation Agent Customers List
 Table 154. Small Molecule Protein Degradation Agent Market Trends
 Table 155. Small Molecule Protein Degradation Agent Market Drivers
 Table 156. Small Molecule Protein Degradation Agent Market Challenges
 Table 157. Small Molecule Protein Degradation Agent Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Small Molecule Protein Degradation Agent
 Figure 2. Global Small Molecule Protein Degradation Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Small Molecule Protein Degradation Agent Market Share by Type: 2024 & 2031
 Figure 4. Molecular Gel Degrader Product Picture
 Figure 5. Protein Degradation Targets Chimeras Product Picture
 Figure 6. Global Small Molecule Protein Degradation Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Small Molecule Protein Degradation Agent Market Share by Application: 2024 & 2031
 Figure 8. Oncology Treatment
 Figure 9. Cancer Treatment
 Figure 10. Treatment Of Neurodegenerative Diseases
 Figure 11. Other
 Figure 12. Global Small Molecule Protein Degradation Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Small Molecule Protein Degradation Agent Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Small Molecule Protein Degradation Agent Sales (2020-2031) & (K Units)
 Figure 15. Global Small Molecule Protein Degradation Agent Average Price (US$/Unit) & (2020-2031)
 Figure 16. Small Molecule Protein Degradation Agent Report Years Considered
 Figure 17. Small Molecule Protein Degradation Agent Sales Share by Manufacturers in 2024
 Figure 18. Global Small Molecule Protein Degradation Agent Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Small Molecule Protein Degradation Agent Players: Market Share by Revenue in Small Molecule Protein Degradation Agent in 2024
 Figure 20. Small Molecule Protein Degradation Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Small Molecule Protein Degradation Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Small Molecule Protein Degradation Agent Sales Market Share by Country (2020-2031)
 Figure 23. North America Small Molecule Protein Degradation Agent Revenue Market Share by Country (2020-2031)
 Figure 24. United States Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Small Molecule Protein Degradation Agent Sales Market Share by Country (2020-2031)
 Figure 27. Europe Small Molecule Protein Degradation Agent Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Small Molecule Protein Degradation Agent Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Small Molecule Protein Degradation Agent Revenue Market Share by Region (2020-2031)
 Figure 35. China Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Small Molecule Protein Degradation Agent Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Small Molecule Protein Degradation Agent Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Small Molecule Protein Degradation Agent Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Small Molecule Protein Degradation Agent Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Small Molecule Protein Degradation Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Small Molecule Protein Degradation Agent by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Small Molecule Protein Degradation Agent by Type (2020-2031)
 Figure 54. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Small Molecule Protein Degradation Agent by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Small Molecule Protein Degradation Agent by Application (2020-2031)
 Figure 57. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Application (2020-2031)
 Figure 58. Small Molecule Protein Degradation Agent Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS